APA (7th ed.) Citation
(2026). Dynamic therapeutic response to osimertinib and immunotherapy in an EGFR L747S and L858R co-mutant NSCLC. The Oncologist.
Chicago Style (17th ed.) Citation
"Dynamic Therapeutic Response to Osimertinib and Immunotherapy in an EGFR L747S and L858R Co-mutant NSCLC." The Oncologist 2026.
MLA (9th ed.) Citation
"Dynamic Therapeutic Response to Osimertinib and Immunotherapy in an EGFR L747S and L858R Co-mutant NSCLC." The Oncologist, 2026.
Warning: These citations may not always be 100% accurate.